Articles from iSono Health
iSono Health, a pioneer in women’s health imaging, today announced the commercial launch of ATUSA™, an FDA-cleared, wearable, and automated 3D quantitative breast ultrasound platform. Designed to bring high-quality imaging into everyday clinics, ATUSA™ unlocks the $14B U.S. breast imaging market by eliminating reliance on hard-to-find skilled sonographers and cost-prohibitive equipment.
By iSono Health · Via Business Wire · January 14, 2026